MyCellHub takes LRM on board in second capital round

1 million euro for SaaS-platform in biopharma : MyCellHub takes LRM on board in second capital round

Hasselt – MyCellHub raises one million euros from the Limburg Investment Company LRM and its existing shareholders, being Gemma Frisius Fund, KU Leuven, Noshaq SA, CoFoundry NV and The Faktory Fund. MyCellHub is a modular data management and analysis (SaaS) platform that streamlines and automates complex workflows in the bio-manufacturing industry. It can count among its customers companies like eTheRNA immunotherapies, TRU Cleanroom Cleaning and EXO Biologics. The funds will be used to integrate new software developments and focus on marketing, sales and internationalisation.

Read more